BIVI•globenewswire•
Join Biovie’s Exclusive Live Investor Webinar and Q&A Session on December 9
Summary
CARSON CITY, Nev., Nov. 19, 2025 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for neurological and neurodegenerative diseases, is pleased to invite investors to a webinar on December 9, 2025, at 4:15 p.m. ET.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on November 19, 2025 by globenewswire